Cargando…
Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?
In situ pulmonary arterial thrombosis in COVID-19 is not visible on CTPA. However, the presence of CT-measured right heart and pulmonary artery dilatation in COVID-19 is likely attributable to this process and may be a possible surrogate for its detection. https://bit.ly/3g7z5TV
Autores principales: | Dintakurti, Sri Harsha, Kamath, Sanjana, Mahon, Ciara, Singh, Suveer, Rawal, Bhavin, Padley, Simon P.G., Devaraj, Anand, Price, Laura C., Desai, Sujal R., Semple, Tom, Ridge, Carole A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790091/ https://www.ncbi.nlm.nih.gov/pubmed/36751674 http://dx.doi.org/10.1183/23120541.00389-2022 |
Ejemplares similares
-
Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
por: Ridge, Carole A, et al.
Publicado: (2020) -
Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021) -
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations
por: Patel, Brijesh V., et al.
Publicado: (2020) -
EP06.01-008 COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
por: Sheeka, A., et al.
Publicado: (2022) -
“ILD” after COVID‐19 Infection: A Catalogue of Uncertainties
por: Wells, Athol U., et al.
Publicado: (2021)